Teva Pharmaceutical Industries Ltd (TEVA)
12.78
-0.40
(-3.03%)
USD |
NYSE |
Apr 18, 16:00
12.55
-0.23
(-1.80%)
Pre-Market: 06:04
Teva Pharmaceutical Industries Cash from Investing (TTM): 968.00M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 968.00M |
| September 30, 2023 | 835.00M |
| June 30, 2023 | 798.00M |
| March 31, 2023 | 676.00M |
| December 31, 2022 | 656.00M |
| September 30, 2022 | 734.00M |
| June 30, 2022 | 875.00M |
| March 31, 2022 | 1.176B |
| December 31, 2021 | 1.523B |
| September 30, 2021 | 1.418B |
| June 30, 2021 | 1.287B |
| March 31, 2021 | 1.119B |
| December 31, 2020 | 863.00M |
| September 30, 2020 | 1.152B |
| June 30, 2020 | 1.219B |
| March 31, 2020 | 1.335B |
| December 31, 2019 | 1.355B |
| September 30, 2019 | 999.00M |
| June 30, 2019 | 1.122B |
| March 31, 2019 | 1.099B |
| December 31, 2018 | 1.866B |
| September 30, 2018 | 3.704B |
| June 30, 2018 | 3.461B |
| March 31, 2018 | 2.969B |
| December 31, 2017 | 3.446B |
| Date | Value |
|---|---|
| September 30, 2017 | 2.072B |
| June 30, 2017 | -30.33B |
| March 31, 2017 | -30.47B |
| December 31, 2016 | -34.40B |
| September 30, 2016 | -35.24B |
| June 30, 2016 | -3.071B |
| March 31, 2016 | -7.763B |
| December 31, 2015 | -5.565B |
| September 30, 2015 | -5.619B |
| June 30, 2015 | -6.011B |
| March 31, 2015 | -1.281B |
| December 31, 2014 | -1.45B |
| September 30, 2014 | -1.419B |
| June 30, 2014 | -1.19B |
| March 31, 2014 | -1.269B |
| December 31, 2013 | -1.147B |
| September 30, 2013 | -1.24B |
| June 30, 2013 | -1.19B |
| March 31, 2013 | -1.206B |
| December 31, 2012 | -1.134B |
| September 30, 2012 | -6.216B |
| June 30, 2012 | -7.161B |
| March 31, 2012 | -7.119B |
| December 31, 2011 | -7.601B |
| September 30, 2011 | -2.326B |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
656.00M
Minimum
Dec 2022
1.523B
Maximum
Dec 2021
1.058B
Average
1.119B
Median
Mar 2021
Cash from Investing (TTM) Benchmarks
| Viatris Inc | -764.10M |
| Johnson & Johnson | 878.00M |
| GSK PLC | -1.985B |
| Novartis AG | 5.596B |
| Sanofi SA | -- |